Sandoz Acquisitions Will Contribute $1.3 Bil. To 2005 Sales, Novartis Says
The integration of the generic drug makers Hexal and Eon Labs into Novartis' Sandoz unit is proceeding ahead of schedule, Novartis reported
The integration of the generic drug makers Hexal and Eon Labs into Novartis' Sandoz unit is proceeding ahead of schedule, Novartis reported